Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Simoons

Showing results (261-270 of 338) with videos related to

Pageof 34
Sort By:
Lancet (London, England)|September 14, 1985
Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The NetherlandsM L Simoons, P W Serruys, M vd Brand, et al.
European Heart Journal|April 1, 1988
Immediate PTCA after successful thrombolysis with intracoronary streptokinase, three years follow-up. A matched pair analysis of the effect of PTCA in the randomized multicentre trial of intracoronary streptokinase, conducted by the Interuniversity Cardiology Institute of The NetherlandsF Vermeer, M L Simoons, P J de Feyter, et al.
European Heart Journal|February 1, 2003
Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCAT Lenderink, E Boersma, C Heeschen, et al.
JAMA|July 4, 2001
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary interventionK M Akkerhuis, J W Deckers, A M Lincoff, et al.
Journal of the American College of Cardiology|May 20, 1999
Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot studyL F van den Merkhof, F Zijlstra, H Olsson, et al.
Journal of the American College of Cardiology|September 15, 2000
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevationD Hasdai, R A Harrington, J S Hochman, et al.
European Heart Journal|July 22, 1999
Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable anginaP Klootwijk, T Lenderink, S Meij, et al.
Heart (British Cardiac Society)|August 19, 2003
Aortic valve and aortic arch pathology after coarctation repairJ W Roos-Hesselink, B E Schölzel, R J Heijdra, et al.
Circulation|April 1, 1995
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I InvestigatorsR J Simes, E J Topol, D R Holmes, et al.
Heart (British Cardiac Society)|August 18, 2004
Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisationM Bountioukos, A Elhendy, R T van Domburg, et al.
Pageof 34

Showing results (261-270 of 338) with videos related to

Sort By:
Pageof 34
Lancet (London, England)|September 14, 1985
Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The NetherlandsM L Simoons, P W Serruys, M vd Brand, et al.
European Heart Journal|April 1, 1988
Immediate PTCA after successful thrombolysis with intracoronary streptokinase, three years follow-up. A matched pair analysis of the effect of PTCA in the randomized multicentre trial of intracoronary streptokinase, conducted by the Interuniversity Cardiology Institute of The NetherlandsF Vermeer, M L Simoons, P J de Feyter, et al.
European Heart Journal|February 1, 2003
Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCAT Lenderink, E Boersma, C Heeschen, et al.
JAMA|July 4, 2001
Risk of stroke associated with abciximab among patients undergoing percutaneous coronary interventionK M Akkerhuis, J W Deckers, A M Lincoff, et al.
Journal of the American College of Cardiology|May 20, 1999
Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot studyL F van den Merkhof, F Zijlstra, H Olsson, et al.
Journal of the American College of Cardiology|September 15, 2000
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevationD Hasdai, R A Harrington, J S Hochman, et al.
European Heart Journal|July 22, 1999
Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable anginaP Klootwijk, T Lenderink, S Meij, et al.
Heart (British Cardiac Society)|August 19, 2003
Aortic valve and aortic arch pathology after coarctation repairJ W Roos-Hesselink, B E Schölzel, R J Heijdra, et al.
Circulation|April 1, 1995
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I InvestigatorsR J Simes, E J Topol, D R Holmes, et al.
Heart (British Cardiac Society)|August 18, 2004
Prognostic value of dobutamine stress echocardiography in patients with previous coronary revascularisationM Bountioukos, A Elhendy, R T van Domburg, et al.
Pageof 34